Coronavirus (COVID-19) - continually updated information

Information for customers, external partners and potential visitors to the EPO

Last updated: 18 September 2020

EPO President António Campinos

In view of the present situation with coronavirus (COVID-19) the European Patent Office (EPO) is adopting the following preventive measures.

We understand this may cause some business disruption and apologise for any inconvenience caused. We are continuously monitoring the situation and will provide updates as necessary.

Coronavirus: message to our users

To all our users,

Since the outbreak of coronavirus our Office has taken measures to ensure the health of our staff and continue to fulfil our mission to our users. Now more than ever, Europe needs a Patent Office that can support innovation in making our world safer, smarter and more sustainable - something which I talk about in the video above.

We are going to support you, our users, in getting through whatever trials you face in the patent system, and whatever the obstacles ahead. We will do so by continuing to search for new, easier ways to interact. We will adapt to your needs as they evolve. We will give you predictability, quality and timeliness, by making sure we deliver all the other goals in our strategic plan.

We understand that you may have questions or concerns about your patent applications or any of the other services we offer. Our staff are on hand to help and answer any queries you may have, via the contact form or by phone. You can also find regular updates on the ongoing measures we're taking, and any effects on our services, on this webpage. Its contents will be updated continuously to give you instant access to the latest information.

Above all, take care of yourselves, and I wish you and your loved ones good health

António Campinos

Oral Proceedings before Examining and Opposition Divisions

In view of the ongoing disruptions caused by the spread of coronavirus (COVID-19) the European Patent Office (EPO) has decided to postpone until further notice all oral proceedings in opposition scheduled until 31 December 2020 (previously until 14 September 2020) which have not either already been confirmed to take place by videoconference or will be held by videoconference with the parties' consent under the pilot project (Article 2 of the Decision of the President of the EPO dated 14 April 2020 concerning the pilot project for oral proceedings by videoconference before opposition divisions). Oral proceedings in examination will continue to be held by videoconference in accordance with the Decision of the President of the EPO dated 1 April 2020 concerning oral proceedings by videoconference before examining divisions.

Oral Proceedings before the Boards of Appeal

Joint statement of the IP5 heads of office

21 July 2020

The heads of the IP5 offices, namely the China National Intellectual Property Administration (CNIPA), the European Patent Office (EPO), the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), and the United States Patent and Trademark Office (USPTO), held their 13th annual meeting for the first time via videoconference on 21 July 2020. The meeting was originally scheduled to be held in June in Chengdu, China, but was postponed due to the COVID-19 pandemic. The videoconference was chaired by Dr. Shen Changyu, Commissioner of the CNIPA and was also attended by the World Intellectual Property Organization (WIPO) in an observer capacity.

The IP5 heads also took stock of the measures put in place by each of the five offices to mitigate the effects of the COVID-19 pandemic on applicants and to promote innovation that is instrumental in winning the battle against this virus. These include providing assistance and relief to those affected by the outbreak, and continuing to facilitate access to patent information, which presents a wealth of technological knowledge related to the detection, prevention and treatment of COVID-19. They stressed that, through all of these measures, the five offices continue to support inventors and researchers everywhere with high-quality IP rights that help them to attract investment, enter new markets, and foster technology transfer.

The five offices will continue the co-operation with the WIPO and support its activities to uphold and strengthen balanced intellectual property systems around the world.

The heads of office also reaffirmed the importance of stakeholder engagement in IP5 cooperation. The five offices have maintained close communication with IP5 industry associations to keep them informed about both the offices' measures in response to COVID-19 and progress on IP5 projects. The heads welcomed efforts of IP5 Industry to work actively with the five offices and to provide input for current and future IP5 initiatives.

Acknowledging the importance of further strengthening the IP5 cooperation and the needs of patent system users for predictability, quality and timeliness, they reiterated their joint commitment to "provide better services to users and the public, so as to enhance the role of intellectual property in stimulating innovation and promoting socio-economic development". To this aim, they confirmed that the five offices, during this crucial period, will continue to:


  • Develop initiatives and share best practices to spur and incentivize innovation, so as to support innovators and the international IP community in their contributions to the recovery of our economies and societies.
  • Pursue IP5 initiatives to advance cooperation in new emerging technologies and artificial intelligence; enhance harmonization of practices and procedures; strengthen work-sharing efforts; improve the quality and efficiency of examination; and further enhance access to patent information.
António Campinos
President
European Patent Office


Kasutani Toshihide
Commissioner
Japan Patent Office

Park Wonjoo
Commissioner
Korean Intellectual Property Office

Shen Changyu
Commissioner National Intellectual Property Administration of the People’s Republic of China

Andrei Iancu
Director
United States Patent and Trademark Office

Joint statement of EPO and JPO on response to COVID-19

EPO logo
JPO logo

Committed to common solutions to global challenges
A joint message from the EPO and the JPO

16 July 2020

The European Patent Office (EPO) and the Japan Patent Office (JPO) express their deepest sympathy for the loss of life resulting from the COVID-19 pandemic, and declare their solidarity with all those suffering personal and economic hardships.

Global solidarity and co-operation are needed more than ever before to defeat the virus and ensure a swift recovery from the economic and social effects of the pandemic. Innovation will play a central role in these efforts, supported by effective intellectual property protection.

The EPO and the JPO have responded to the crisis by adapting our services and procedures in support of inventors. Both of our Offices have offered assistance to patent applicants by providing flexibility with regard to procedural deadlines, along with a wide range of other measures to ensure business continuity[1].

We stand by inventors and researchers, and will continue to support their efforts in developing technological solutions to this global challenge by offering access to patent information on technologies, through our free public patent databases so that they can build on previous advances. We will provide solid IP rights that enable scientists, inventors, and researchers to innovate further, helping them to attract investment, bring their technologies to market, and create jobs.

The EPO has launched a tool to provide insight on patent landscapes related to coronavirus, which supports scientists and researchers with ready-made search strategies. The JPO also offers a tool in the form of an open licensing database, where businesses can connect, and find information on available technologies.

Over the years we have established various joint initiatives to support inventors worldwide, such as fast-tracking examination of patent applications through the Patent Prosecution Highway programme, and promoting the alignment of our examination practices and procedures, for example in the area of computer-implemented inventions.

We reaffirm our commitment to addressing the challenges together and building further on the longstanding and productive co-operation between the EPO and the JPO. Companies and inventors from Japan and Europe have always figured prominently among the applicants at both Offices: last year Japanese and European firms filed more than 20 000 patent applications with the EPO and the JPO respectively.

Due to the global nature of innovation today, with scientists, companies and researchers co-operating across borders, we are determined to seek global solutions for the benefit of the international IP community, and to advance bilateral co-operation initiatives. We will intensify our joint work towards an efficient and harmonised international patent system, in particular within the framework of the Trilateral co-operation together with the United States Patent and Trademark Office, and the IP5[2], which also includes the China National Intellectual Property Administration and the Korean Intellectual Property Office.

Together the EPO and the JPO will contribute to the economic and social recovery from the pandemic by collaborating on intellectual property issues in support of innovators worldwide to promote an efficient, cost-effective and user-friendly international patent landscape.


  • António Campinos
    EPO President
  • MATSUNAGA Akira
    JPO Commissioner

1 To find out more about measures implemented by the EPO and the JPO in response to the coronavirus pandemic, please visit our websites, www.epo.org/news-issues/covid-19.html and www.jpo.go.jp/e/news/koho/saigai/covid19_procedures.html.
2 To read more about the Offices' initiatives for effective multilateral co-operation on global IP issues, visit the IP5 website: www.fiveipoffices.org

Joint statement of EPO and KIPO on response to COVID-19

EPO logo
KIPO logo

16 July 2020

Joint message from the EPO and the KIPO on COVID-19

In the face of the unprecedented global challenges posed by the coronavirus (COVID-19) pandemic, the European Patent Office (EPO) and the Korean Intellectual Property Office (KIPO) stand united in expressing their deepest sympathy with the families of the COVID-19 victims, and understanding for our users, who are experiencing hardships - whether directly or indirectly - in their daily lives.

Europe and South Korea have both been affected by the outbreak and spread of the disease. More recently, both our regions have witnessed a gradual decrease in the number of newly confirmed cases - in no small part due to innovative medical technologies and even IT solutions being deployed to help health workers, authorities and the public contain the spread of the virus.

The EPO and the KIPO firmly believe that innovation is the key to putting an end to the coronavirus pandemic and rebuilding the global economy and trade. Innovative companies and research centres across a wide range of medical fields are working hard on developing and testing COVID-19 vaccines and treatments. Others are keenly developing new unmanned or contactless technologies that could offer new hope for economic revival.

Over the past two decades, the EPO and the KIPO, through our individual and collective efforts, have strived to provide high-quality patent examination, to deliver reliable patents in a timely manner and to help innovators benefit from a variety of bilateral co-operation programmes. In addition, both of our Offices manage patent databases that contain vast amounts of accumulated knowledge and technologies from around the world. These databases have been made accessible to the public free of charge so that innovators can easily gain the insights they need to build a better future.

Since the coronavirus outbreak, the EPO and the KIPO have taken remedial measures to maintain the drive for innovation by minimising the adverse impact of the crisis on our users. We extended the deadlines for certain applicant actions for their ongoing applications, such as required document submission and fee payment, to help them avoid unintentional non-observance of time limits due to COVID-19 disruptions. We have introduced new online tools and services, which have also helped to ensure proceedings continue in an era of social distancing. In addition, both Offices have made up-to-date patent databases available to innovators for coronavirus-related technologies including diagnosis, prevention and treatment.

In these challenging times we are once again reminded of the importance of co-operation as a powerful driver for Europe and South Korea to navigate crises and move forward. The pandemic transcends borders and requires greater solidarity and co-operation. The EPO and the KIPO believe we will be able to overcome this crisis by continuing to work together to promote and utilise innovation. We will remain committed to strengthening our longstanding co-operation and supporting the innovation community.

  • António Campinos
    EPO President
  • Park Wonjoo
    KIPO Commissioner

Joint statement of EPO and CNIPA on response to COVID-19

EPO CNIPA logos30 June 2020

Joint statement of EPO and CNIPA on response to COVID-19

The European Patent Office (EPO) and the China National Intellectual Property Administration (CNIPA) stand in full solidarity with all those affected by COVID-19.

After over three decades of strong bilateral co-operation, the EPO and CNIPA have built a comprehensive strategic partnership that contributes to higher quality patents and greater harmonisation in the patent system. The relationship between China and Europe is also reflected in the growing number of applications received by the EPO and the CNIPA. In 2019 the EPO received almost 30% more applications from the People's Republic of China than in the previous year. EPC member countries also filed 42,000 invention patent applications in China, marking an increase of 4.9% over the previous year.

As the economic effects of coronavirus start to materialise, business continuity is needed more than ever. Industries that intensively use intellectual property rights play a fundamental role in supporting our economies. In the EU they generate 39% of EU employment and 45% of GDP. Similarly, in 2018, the added value of China's patent-intensive industries reached 10.7 trillion Yuan, accounting for 11.6% of GDP, becoming an important support for the high-quality development of China's economy. Going forward, these industries will prove instrumental in the recovery of the global economy.

The EPO and the CNIPA are fully committed to implementing measures that ensure users across the world have access to high-quality patent protection in Europe and the People's Republic of China. Specifically, the EPO has extended time limits and fee deadlines, as well as offering users greater flexibility by holding oral proceedings via video conferences, while the CNIPA has restored rights, reduced requested certification materials and waived fees for overdue patent annual fee payment. These measures have provided unprecedented levels of support for users.

The EPO and the CNIPA will continue to support the fight against the pandemic by enriching public patent databases and making sources of patent information available. These information sources are pivotal for all those who play a central role in our societies' efforts to defeat COVID-19, including research institutions and universities. The patent literature provided by both Offices is crucial for research, as consulting our patent databases enables scientists to constantly monitor state-of-the-art innovation and develop it further. Public databases such as Espacenet contain over110 million patent documents from around the world. The CNIPA's Patent Search and Analysis System provides enriched search and research functions, including medicine search and patent analysis, among others.

In the current difficult time of the global spread of the COVID-19 pandemic, the EPO and the CNIPA are united in our efforts to support users based on the long-term, friendly and dynamic co-operation between our Offices. We will work together to ensure that our Offices continue to support users as they navigate the challenges created by the global pandemic and as they emerge into a post-coronavirus landscape.

  • António Campinos
    EPO President
  • Shen Changyu
    CNIPA Commissioner

Consultation of contracting states on extensions or interruptions of periods

The documents below provide users with an overview of the measures taken by the EPC contracting states with respect to extensions or interruptions of periods, if any, with regard to proceedings before their national industrial property offices. It is based on information communicated to the EPO by the national offices of the EPC contracting states. Please note that the measures at national level are subject to changes and updates given the dynamic situation. Users should therefore consult the national industrial property offices and the official publications of the EPC contracting states to make sure that the indications are fully accurate and still up to date.

Remedies in case of non-observance of time limits

In view of the disruptions to public life caused by the COVID-19 outbreak, the EPO is drawing attention to the legal remedies applicable in case of non-observance of time limits. These remedies are available for users located in areas directly affected by disruptions due to the COVID-19 outbreak and apply to parties and representatives in proceedings under the EPC and the PCT. The following notice provides all relevant information, replaces the previous Notice dated 1 May 2020 and will be published in the EPO’s June Official Journal

The extension of time limits also applies to periods for paying fees, including renewal fees. The following notice contains information about the amounts due following the general fee increase on 1 April 2020.

Other measures as regards the payment of fees in the context of the COVID-19 pandemic

Following the decision of the Administrative Council CA/D 6/20 dated 28 May 2020 it is possible as of 1 June 2020 to pay renewal fees due on or after 15 March 2020 up until 31 August 2020 inclusive without being charged the additional fee under Rule 51(2) EPC.

For more information on this measure, please consult the Notice from the European Patent Office dated 29 May 2020 concerning the temporary suspension of the application of Rule 51(2) of the European Patent Convention with respect to an additional fee for the late payment of renewal fees for patent applications (Article 2(1), item 5, of the Rules relating to fees).

Using electronic filing, receiving electronic notifications and staying informed via electronic alerts

The COVID-19 outbreak has led to disruptions in the postal services in a number of countries and to restrictions on people's movements. The EPO offers its users various services which can help them to communicate with it and keep up to date despite this situation and would therefore like to draw your attention to the following options for electronic filing, receiving electronic notifications and staying informed of procedural events via electronic alerts.

Electronic filing

European applications, international applications under the PCT and subsequent submissions can be filed using one of the EPO's electronic filing tools Online Filing, web-form filing (WFF) or new online filing (CMS) or by fax (see Rule 2 EPC, Rule 89.bis PCT, Guidelines A-II, 1.2-1.4, OJ EPO 2018, A45, A46). The ePCT system can also be used for international applications under the PCT and subsequent filings. An overview of the various filing options is available in this comparative table. The option of filing by WFF is especially helpful if you do not have a smart card or cannot use it. All you need to do to use WFF is register. More detailed information about WFF can be found here on the EPO website and in the related FAQ.

At present, the use of email to perform procedural acts is restricted: the EPO allows email submissions during telephone consultations and interviews and oral proceedings held as a videoconference (Decision of the President of the European Patent Office dated 13 May 2020). Apart from this exception, however, email filing cannot be used to validly perform any procedural act under the EPC or the PCT and, in particular, cannot be used to comply with time limits (see OJ EPO 2000, 458).

Electronic notification and electronic alerts

The following EPO or WIPO services allow you to receive notifications or alerts from the EPO electronically or to access your files online.

  • EPO My Files service: This service enables applicants to access their published and unpublished European application files via a secure connection, using a smart card and PIN. More information is available here on the EPO website, including an online tutorial, a quick reference guide and a FAQ section.
  • EPO Register Alert service: This alert service allows you to monitor changes to data in the European Patent Register for published European applications and published Euro-PCT applications which have entered the European phase. You can keep track of up to 1000 applications and patents of your choice and opt to receive an email alert whenever there is a change triggering a register event. Register events include notifications from the EPO. The document associated with a new entry can be accessed via the European Patent Register. You can even use this service to monitor your own applications by selecting them in the tool. More information is available here on the EPO website, including an introductory video and a FAQ section.
  • WIPO's ePCT system: Applicants who open an ePCT account (here on the WIPO website) can:
    • file international applications with the RO/IB, RO/EP or any other participating receiving Office;
    • electronically access their applications (either filed through their ePCT account or linked to it) at any time;
    • submit documents to the IB, RO/EP, ISA/EP, IPEA/EP and other participating Authorities by upload;
    • change their account settings to receive automatic email notifications of any documents newly added by any Authority (RO, ISA/IPEA, IB);
    • access any documents issued by any Authority (RO, ISA/IPEA, IB).

The EPO does not send notifications or advance copies of communications by email in proceedings under either the EPC or the PCT. However, it may exceptionally use additional means of communication (e.g. email) to send parties advance copies of communications informing them of cancellations and postponements of oral proceedings.

A joint message of support for inventors from the USPTO and EPO

EPO USPTO logos30 April 2020

Responding to COVID-19
A joint message of support for inventors from the USPTO and EPO

The coronavirus outbreak has changed our daily lives almost beyond recognition. The staff of the European Patent Office (EPO) and United States Patent and Trademark Office (USPTO) stand in solidarity with everyone affected.

Beyond the instances of personal hardship, we are now seeing a significant negative impact on the global economy. Every day, we learn further of the economic effects in nations in various degrees of lockdown.

In these challenging times, it is our innovators, inventors and all those involved in pioneering research who will play a central role in the recovery of our economies and societies. In both the US and Europe, industries that make intensive use of intellectual property rights (IPR) generate approximately 40% of GDP and are directly and indirectly responsible for around 30% of jobs. They are the driving force behind exports, amounting to more than one trillion USD or EUR each year.

Among these IPR-intensive industries are the innovative companies, research centers and universities that are researching and developing tests, vaccines, and treatments that could put an end to the coronavirus pandemic. Their work is fundamental to us as people and as a society fighting to take care of its vulnerable members and those in need of medical care. Indeed, such innovation has long served as the driving engine of human development, and will continue to do so.

To support innovation during this crisis, the USPTO and the EPO stand shoulder-to-shoulder with the innovation community. Our Offices are now offering assistance through time extensions and fee deadlines, as well as flexibility on hearings, such as offering video conferences or postponements.1 By doing so, we hope to continue supporting inventors with high-quality intellectual property rights that help them attract investment and licence technology, create jobs, and enter new markets with confidence and predictability.

Our Offices will spare no effort to give users the support they need. We will develop our capacity to respond to the difficult circumstances that applicants face. At a time when the dissemination of knowledge is crucial, we will persevere in developing the tools that can help scientists all over the world. We will continue to enrich our public patent databases, which are free to access and contain hundreds of millions of documents from all over the world. They present a wealth of technological knowledge that can help inventors and researchers everywhere build on previous developments, gain new insight and help identify potential suppliers, technology partners, and customers.

The USPTO and the EPO stand united in our effort to support the public in this crucial time, and we will build on our longstanding relationship to provide everyone in the IP community with the support they need.

  • Andrei Iancu
    USPTO Director
  • António Campinos
    EPO President

1 For more information on how the USPTO and EPO are adapting their services and regulations in response to the coronavirus pandemic, see their websites: www.epo.org/news-issues/covid-19.html and www.uspto.gov/coronavirus.

EQE

EQE 2020 - CANCELLED

The Supervisory Board has decided to cancel the EQE 2020 in its entirety without replacement (pre-examination and main examination papers).

Since the cancellation of the examination dates of 16-19 March 2020 the EPO has made every effort to find a suitable alternative to these dates. However, it remains uncertain as to whether the strict anti-COVID-19 measures taken by the governments of most countries to protect the health and safety of the public in general will be lifted in time for an EQE 2020 to be held later this year.

We know how important the EQE is to the patent world and how much effort and time candidates invest in preparing for the examination, but in view of the current situation and the lack of certainty with regard to the future, we trust that everyone will understand the reasons for this decision.

In these exceptional circumstances, the EPO and epi have made a thorough search for alternatives to ease this inconvenient situation for candidates of 2020 EQE as far as possible. Ease of access to EQE 2021 will be created for these candidates as follows: all candidates who had enrolled for the 2020 pre-examination paper will be allowed to enrol for the 2021 main examination without having passed a pre-examination. This will also be possible for registered candidates who have completed the required professional activities/training period. Candidates who had enrolled for 2020 main examination papers will be considered to be enrolled for those papers in 2021.

For future examinations, with a view to saving resources and rendering procedures more efficient – also for the benefit of candidates - the EPO, together with the epi, will explore all possibilities to arrive at a paperless process and procedures. This will be advantageous not just for the EQE but for all procedures.

Events

All EPO organised live events scheduled up until 31 December 2020 are now expected to take place online, unless indicated otherwise.

The 2020 edition of the European Inventor Award, planned to be held in Monaco on 17-18 June, has also been postponed. The event will take place in Monaco on 17 June 2021.

EPO customer services

During this exceptionally challenging time, maintaining high-quality services and an open dialogue with our users remains a top priority. Our customer services helpdesk remains fully operational and available to answer your questions on any aspect of the EPO and our operations.

For health and safety reasons, all our customer service agents have been fully equipped to work from home. You can therefore continue to expect the same level of service that underpins our commitment to quality for all users. Our dedicated key account managers are also reaching out to their customers to keep them up-to-date on any developments.

When requesting a smart card, if you are not a professional representative before the EPO or an otherwise authorised employee and there is no authorised person available to countersign your request, please attach a copy of your ID card, passport or driving licence.

We have upped our capacity in preparation for an increase in requests for smart card readers.

Feel free to contact us by email at support@epo.org, via the website contact form or by telephone. (Customer services are available by phone from Monday to Friday between 08:00 and 18:00 CET.)

External partners / visitors

We are asking all visitors to abstain from visiting the EPO if they have recently visited a high risk area, unless they confirm they had a negative result from a test that was taken at the earliest on the fifth day after they left the high-risk area. Earlier tests cannot be accepted. Visitors will be required to sign a declaration of the areas visited in the two weeks prior to their planned visit to the Office.

For oral proceedings, please see the relevant section above.

Staff working from home

Staff at all sites are being provided the means to work from home and many are doing so. The Office fully remains at the service of users and we will ensure the full functioning of our technical infrastructure. Further updates may follow.

Chronological list of updates to this page

The following is a chronological list of updates and amendments to this webpage from 11 May provided as a courtesy to readers.

In urgent situations where speed of action takes precedence, updates may initially appear in English only, even on the German and French pages. Corresponding translations will be added as they become available. The addition of translations is not included in the list below.

Updated on Time of update Reason for update
18.9.2020
17.30 hrs CET
Section updated: External partners / visitors
14.9.2020
15.30 hrs CET
Section updated: Oral Proceedings before Examining and Opposition Divisions  
21.8.2020
17.00 hrs CET
Sections updated: External partners / visitors, High risk areas
3.8.2020
17.00 hrs CET
Section updated: Events 
30.7.2020
15:30 hrs CET
New section added: Joint statement of the IP5 heads of office
29.7.2020
13:30 hrs CET
Section updated: Oral Proceedings before Examining and Opposition Divisions 
29.7.2020
13:30 hrs CET
Section updated: Oral Proceedings before the Boards of Appeal  
16.7.2020
09.00 hrs CET
New section added: Joint statement of EPO and JPO on response to COVID-19
16.7.2020
09.00 hrs CET
New section added: Joint statement of EPO and KIPO on response to COVID-19
9.7.2020
14.30 hrs CET
Section updated: Oral Proceedings before Examining and Opposition Divisions
3.7.2020
11.15 hrs CET
Section updated: Oral Proceedings before Examining and Opposition Divisions
3.7.2020
09.00 hrs CET
Sections updated: External partners / visitors; High risk areas 
30.6.2020
08.00 hrs CET
New section added: Joint statement of EPO and CNIPA on response to COVID-19  
24.6.2020
16.40 hrs CET
Section updated: Consultation of contracting states on extensions or interruptions of periods
12.6.2020
10.00 hrs CET
Section updated: Events
10.6.2020 20.00 hrs CET New section added: Consultation of contracting states on extensions or interruptions of periods
3.6.2020
12.00 hrs CET
Section updated: Remedies in case of non-observance of time limits
3.6.2020
07.50 hrs CET
Section updated: Remedies in case of non-observance of time limits
3.6.2020
00.10 hrs CET
Section updated: Remedies in case of non-observance of time limits
27.5.2020
15.30 hrs CET
Section updated: Remedies in case of non-observance of time limits
25.5.2020
16.40 hrs CET
Section updated: Oral Proceedings before the Boards of Appeal
21.5.2020
15.00 hrs CET
Section updated: Oral Proceedings before Examining and Opposition Divisions
19.5.2020
16.00 hrs CET
Section updated: Oral Proceedings before the Boards of Appeal
19.5.2020
13.00 hrs CET
Section updated: Oral Proceedings before Examining and Opposition Divisions
19.5.2020
12.30 hrs CET
Section updated: Remedies in case of non-observance of time limits
15.5.2020
11.00 hrs CET
Section updated: Staff working from home
15.5.2020
08.00 hrs CET
Section updated: Oral Proceedings before the Boards of Appeal
14.5.2020
08.00 hrs CET
Section updated: Using electronic filing, receiving electronic notifications and staying informed via electronic alerts
13.5.2020
20.00 hrs CET Section updated: Oral Proceedings before Examining and Opposition Divisions
13.5.2020
14.30 hrs CET Section updated: Oral Proceedings before Examining and Opposition Divisions
11.5.2020 15.00 hrs CET New section added: Chronological list of updates to this page

High risk areas

Please refer to the risk areas as defined by the national authorities in your host country.

Please note that the definition of areas affected by the spread of coronavirus may be subject to change.

Quick Navigation